Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108.70 EUR | -1.72% | -0.64% | +0.74% |
Dec. 03 | Ipsen: exclusive worldwide licensing agreement with Biomunex | CF |
Dec. 03 | Ipsen, Biomunex Sign Licensing Deal for Novel T Cell Engager BMX-502 | MT |
Chart calendar Ipsen
Upcoming events on Ipsen
Past events on Ipsen
2024-11-27 | Societe Generale Premium Review Conference |
2024-11-19 | Deutsche C-Suite Call Series |
2024-11-19 | CIC Market Solutions Forum |
2024-11-18 | Jefferies London Healthcare Conference |
2024-11-17 | BNP Exane MidCap CEO Conference |
2024-11-14 | Barclays Hearing out Healthcare Conference |
2024-11-12 | UBS European Conference |
2024-11-05 | Bernstein European Sustainability Conference |
2024-10-23 08:00 am | Q3 2024 Sales and Revenue Call |
2024-10-23 01:00 am | Q3 2024 Sales and Revenue Release |
2024-09-16 08:45 am | European Society Medical Oncology Congress |
2024-07-25 07:00 am | Q2 2024 Earnings Call |
2024-07-25 01:00 am | Q2 2024 Earnings Release |
2024-05-29 | Détachement de for final dividend |
2024-05-28 09:00 am | Annual General Meeting |
2024-04-24 07:00 am | Q1 2024 Sales and Revenue Call |
2024-04-24 01:00 am | Q1 2024 Sales and Revenue Release |
2024-03-11 | Barclays Global Healthcare Conference |
2024-03-04 | TD Cowen Health Care Conference |
2024-02-27 | Morgan Stanley European MedTech and Life Sciences Conference |
Past dividends on Ipsen
2024-05-29 | Annual 1.2 EUR |
2023-06-01 | Annual 1.2 EUR |
2022-05-30 | Annual 1.2 EUR |
2021-05-30 | Annual 1 EUR |
2020-06-02 | Annual 1 EUR |
2019-05-30 | Annual 1 EUR |
2018-06-03 | Annual 1 EUR |
2017-06-08 | Annual 0.85 EUR |
2016-06-01 | Annual 0.85 EUR |
2015-05-28 | 0.85 EUR |
2014-06-08 | Annual 0.8 EUR |
2013-06-04 | Annual 0.8 EUR |
2012-06-05 | Annual 0.8 EUR |
2011-05-31 | Annual 0.8 EUR |
2010-05-31 | Annual 0.75 EUR |
2009-06-08 | Annual 0.7 EUR |
2008-06-05 | Annual 0.66 EUR |
2007-06-05 | Annual 0.6 EUR |
2006-06-04 | Annual 0.6 EUR |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 2 869 2 883 -0.5% | 3 025 3 069 -1.45% | 3 128 3 273 -4.45% | 3 495 | 3 698 | 3 949 |
EBITDA Million EUR | Released Forecast Spread | 1 166 1 095 6.52% | 1 348 1 247 8.12% | 881 1 142 -22.84% | 1 248 | 1 307 | 1 383 |
EBIT Million EUR | Released Forecast Spread | 1 011 954 6% | 1 115 1 090 2.31% | 1 001 974 2.79% | 1 048 | 1 117 | 1 203 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 815 829 -1.74% | 706 945 -25.3% | 762 698 9.04% | 826 | 934 | 1 011 |
Net income Million EUR | Released Forecast Spread | 647 622 3.98% | 648 804 -19.44% | 647 598 8.27% | 630 | 734 | 805 |
EPS EUR | Released Forecast Spread | 7,76 7,45 4.17% | 7,81 9,69 -19.37% | 7,73 7,03 9.9% | 7,51 | 8,68 | 9,61 |
Announcement Date | 11/02/22 | 09/02/23 | 08/02/24 | - |
Quarterly results
Fiscal Period | June | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 816 790 3.34% | 1 591 1 621 -1.83% | 742 709 4.64% | 795 780 1.94% | 1 537 1 528 0.56% | 772 783 -1.4% | 819 | 1 591 1 691 -5.89% | 822 788 4.31% | 837 835 0.2% | 1 659 1 726 -3.86% | 837 822 1.8% | 887 |
EBIT Million EUR | Released Forecast Spread | 547 540 1.45% | 523 528 -0.91% | 478 431 10.91% | 538 520 3.46% | |||||||||
Net income Million EUR | Released Forecast Spread | 253 514 -50.69% | ||||||||||||
EPS EUR | Released Forecast Spread | 3,07 8,33 -63.15% | 2,35 4,27 -44.96% | 5,38 3,48 54.82% | 2,78 3,66 -24.04% | |||||||||
Announcement Date | 09/02/23 | 09/02/23 | 27/04/23 | 27/07/23 | 27/07/23 | 26/10/23 | 08/02/24 | 08/02/24 | 24/04/24 | 25/07/24 | 25/07/24 | - | - |
Past sector events for Ipsen
2024-12-04 02:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release |
2024-11-28 | DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release |
2024-11-15 01:38 am | BAVARIAN NORDIC A/S: Q3 2024 Earnings Release |
2024-11-14 11:01 pm | CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release |
2024-11-14 09:03 am | GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release |
2024-11-14 07:00 am | OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release |
2024-11-14 02:49 am | IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release |
2024-11-14 01:30 am | DERMAPHARM HOLDING SE: Q3 2024 Earnings Release |
2024-11-14 01:30 am | ALK-ABELLÓ A/S: Q3 2024 Earnings Release |
2024-11-13 | DONGKOOK PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IPN Stock
- Calendar Ipsen